Newswire (Published: Monday, October 9, 2017, Received: Thursday, October 5, 2017, 11:43:20 AM CDT)

Word Count: 218

By a News Reporter-Staff News Editor at Clinical Trials Week -- Accuray Incorporated (NASDAQ: ARAY) announced that data from a prospective study of 230 men with low-risk prostate cancer showed 98.4 percent had local disease control 10 years after receiving stereotactic body radiation therapy (SBRT) administered with the CyberKnife® System, and toxicity was mild. The study titled, "Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer: A Ten-Year Analysis," was published online in the September 9, 2017 issue of Cureus (see also Accuray Incorporated).

"This is a groundbreaking study -- the first to report on the efficacy and toxicity of SBRT in the treatment of low-risk prostate cancer following 10 years of treatment. All patients participating in the study were treated with the CyberKnife System, which delivers extremely precise radiation treatments using unique, real-time image guidance and automatic motion correction. The study outcomes were excellent both in terms of disease control and tolerability, and were superior to long-term conventional intensity-modulated radiation therapy, based on results from other studies," said Alan Katz, M.D., Flushing Radiation Oncology.

CyberKnife SBRT provides significant treatment benefits

Keywords for this news article include: Oncology, Prostate Cancer, Clinical Research, Prostatic Neoplasms, Accuray Incorporated, Clinical Trials and Studies.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC


Accuray Incorporated


      Medical Devices
            Medical Treatment Devices
                  Radiosurgery Devices
      Medical Device Manufacturing
            Medical Devices
                  Medical Treatment Devices
                        Radiosurgery Devices


Science and Technology
      Scientific Research
Health and Wellness
      Medical Conditions and Diseases
                  Prostate Cancer
            Men's Health Issues
                  Prostate Cancer
      Medical Specialties and Practices
      Medical and Pharmaceutical Regulation
            Drug and Device Approval Process
      Treatments and Therapies
            Radiation Therapy